演題詳細

一般口演 / Oral Session

一般口演 108 (Oral Session 108) :感染症・その他

print

日程
2013年10月13日(日)
時間
16:00 - 17:00
会場
第14会場 / Room No.14 (札幌市教育文化会館 3F 研修室305)
座長・司会
岩崎 博道 (Hiromichi Iwasaki):1
1:福井大学医学部 感染制御部
 
前へ戻る

Safety and feasibility of peripherally inserted central catheters in hematologic disease patients

演題番号 : OS-3-189

高岩 直子 (Naoko Takaiwa):1、関 正則 (Masanori Seki):1、周山 拓也 (Takuya Suyama):1、真家 紘一郎 (Koichiro Maie):1、小川 晋一 (Shinichi Ogawa):1、栗田 尚樹 (Naoki Kurita):1、横山 泰久 (Yasuhisa Yokoyama):1、坂田 麻実子 (Mamiko Sakata):1、小原 直 (Naoshi Obara):1、鈴川 和己 (Kazumi Suzukawa):1、長谷川 雄一 (Yuichi Hasegawa):1、千葉 滋 (Shigeru Chiba):1

1:Department of Hematology, University of Tsukuba, Japan

 

BACKGROUND: Traditional central venous catheters (CVC) often cause complications such as pneumothorax, hematoma, catheter related blood stream infection (CR-BSI), and so on, and these complications become more of a problem in hematologic diseases-carrying patients. Peripherally inserted central venous Catheters (PICC) are recently expected to reduce these complications. The aim of this study was to compare the rate of complications and risk factors for CR-BSI between CVC and PICC.PATIENTS and METHODS: We retrospectively reviewed 270 patients who had been inserted with PICC or CVC during the hospitalization in 2011 through 2013 at the University of Tsukuba Hospital. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured.RESULTS: The PICC(N=150) and CVC(N=120) had similar background and catheter life time. The significant intergroup differences were found in CR-BSI rates (PICC=3.1/1000 catheter days, CVC=9.7/1000, p<0.001), exit-site infection rates (PICC=0.3/1000 catheter days, CVC=2.7/1000, p=0.003). The cumulative incidence of catheter removal for infective complications was higher in CVC than PICC(PICC 14.5% vs. CVC 47.1%, p=0.01). In multivariate analysis, the rate of CR-BSI (OR, 0.11; 95% CI, 0.21-0.44; p=0.03) was significantly lower for PICC compared to CVC. CONCLUSION: Our data suggests that PICC is superior to CVC in terms of infective complications, and as safe as CVC in other points. So PICC may be more suitable for management of hematologic diseases patients.

前へ戻る